Results 71 to 80 of about 155,199 (206)

Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus

Clinics, 2012
OBJECTIVE: To determine the serum levels of interferon alpha in childhood-onset systemic lupus erythematosus patients, their first-degree relatives and healthy controls and to evaluate the associations between serum interferon alpha and disease activity,
Mariana Postal, Nailu Angélica Sinicato, Karina Oliveira Peliçari, Roberto Marini, Lilian Tereza Lavras Costallat, Simone Appenzeller   +5 more
doaj  

Significant improvement of refractory cutaneous lesions of lupus erythematosus with the use of anifrolumab: a report of two cases

Revista da Sociedade Portuguesa de Dermatologia e Venereologia
Anifrolumab, a monoclonal antibody targeting the interferon-1 receptor, is currently approved for the treatment of moderate- to-severe systemic lupus erythematosus, but emerging evidence highlights its potential efficacy in cases with predominant ...
Gilberto P. da Rosa, Isabel Antunes, Bárbara V. Granja, Patrícia Gomes, Rúben Costa, Filomena Azevedo, Alberto Mota   +6 more
doaj  

Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus

Clinics, 2012
OBJECTIVE: To determine the serum levels of interferon alpha in childhood-onset systemic lupus erythematosus patients, their first-degree relatives and healthy controls and to evaluate the associations between serum interferon alpha and disease activity,
Mariana Postal, Nailu Angélica Sinicato, Karina Oliveira Peliçari, Roberto Marini, Lilian Tereza Lavras Costallat, Simone Appenzeller   +5 more
doaj  

Cutaneous Lupus Erythematosus: Progress and Challenges

Current Allergy and Asthma Reports, 2020
A. J. Petty, Lauren Floyd, C. Henderson, Matilda W. Nicholas   +3 more
semanticscholar   +1 more source

Sex-based clinical and immunological differences across lupus erythematosus subtypes: a cross-sectional multicentre study from China. [PDF]

Lupus Sci Med
Pan Y, Jin H, Zhou S, Ying Z, Bai L, Lu Q.   +5 more
europepmc   +1 more source

Persistent cutaneous lupus erythematosus: A pathway toward systemic disease? [PDF]

J Transl Autoimmun
Wang Q, Chen M, Jin H, Xiao J, Zhang Y.
europepmc   +1 more source

Palmar Cutaneous Erythematous Macules: A Case Report of an Atypical Presentation of Chilblain Lupus Erythematosus. [PDF]

Cureus
Israr Ul Haq M, Mahmood MN, Chow EY.
europepmc   +1 more source

Effect of Belimumab on the Cutaneous Manifestations of Patients With Lupus Erythematosus. [PDF]

Int J Dermatol
Schellin D, Rösing S, Zimmermann N, Leuchten N, Aringer M, Günther C.   +5 more
europepmc   +1 more source

Anifrolumab in Refractory Oral Manifestations in Systemic Lupus Erythematosus: A Case Report and Literature Review. [PDF]

Biologics
Garmish O, Smiyan S, Komorovsky R, Bilozetskyi I.   +3 more
europepmc   +1 more source

Rapid clinical response in refractory discoid lupus erythematosus treated with anifrolumab. [PDF]

An Bras Dermatol
Ramos J, Leme H, Magarreiro-Silva A.
europepmc   +1 more source